An Open-Label, Multicentre, Randomised, Phase III Comparator Study of Active Symptom Control Alone or in Combination With Oral Topotecan in Patients With Relapsed Resistant SCLC.
Phase of Trial: Phase III
Latest Information Update: 12 Apr 2013
At a glance
- Drugs Topotecan (Primary)
- Indications Small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 12 Aug 2010 Additional trial location (Belarus) identified as reported by ClinicalTrials.gov.
- 30 Mar 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History